Skip to content

A Prospective Observational Study to evaluate the comprehensive geriatric assessment (CGA) for tailored treatment in elderly patients with diffuse large B-cell lymphoma

A Prospective Observational Study to evaluate the comprehensive geriatric assessment (CGA) for tailored treatment in elderly patients with diffuse large B-cell lymphoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-16008695
Enrollment
Unknown
Registered
2016-06-20
Start date
2016-06-21
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diffuse large B cell lymphoma

Interventions

Sponsors

Hematology Department of Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: Age:=65 years;Diagnosis of Diffuse large B cell lymphoma by histopathological and immunochemistry based on WHO 2008; All patients have to sign an informed consent document indicating that they understand the purpose of and procedures required for the study and are willing to participate in the study.

Exclusion criteria

Exclusion criteria: patients with a previous history of hematologic malignancy or solid tumor who received chemotherapy or radiation therapy; central nervous system or meningeal involvement;HIV infection.

Design outcomes

Primary

MeasureTime frame
overall survival;progression-free survival;

Secondary

MeasureTime frame
Overall Response Rate;Grade 3/4 toxicities;

Countries

China

Contacts

Public ContactLiu Hui

Beijing Hospital

liuhui8140@126.com+86 010-85136772

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026